Revisiting Vitamin D Guidelines: A Critical Appraisal of the Literature.
Level 5 - mechanism / opinion, no new human data
Narrative review and critical appraisal comparing guidelines without systematic review methodology
PubMed 39486479 · doi:10.1016/j.eprac.2024.10.011
What was done
The author performed a narrative critical appraisal comparing the 2024 and 2011 Endocrine Society Clinical Practice Guidelines on vitamin D supplementation and target circulating levels.
What was found
The abstract reports no primary experimental or statistical calculations. It notes that the 2024 Guideline focused on randomized controlled trials in general healthy populations—recommending empiric supplementation in children aged 1–18 years (for upper respiratory infections), pregnant women, individuals with prediabetes, and adults older than 75 years (for mortality), while advising standard Dietary Reference Intakes (600–800 IU daily) for nonpregnant adults aged 19–75. The review contrasts this with observational evidence and the 2011 Guidelines, which recommended achieving circulating 25-hydroxyvitamin D concentrations of at least 30 ng/mL (preferred range 40–60 ng/mL) for broader extraskeletal benefits.
Why it matters
It highlights ongoing clinical debate between guideline frameworks that prioritize strict randomized trial evidence versus those integrating observational data to define optimal 25-hydroxyvitamin D thresholds.
Limits
This is a narrative commentary presenting expert opinion and comparison; it does not present a systematic review, meta-analysis, or new primary human data. The abstract does not specify search criteria, study counts, or quantitative risk estimates.
Cited by
- supports Vitamin D insufficiency is defined by the Endocrine Society as circulating 25-hydroxyvitamin D levels below 30 ng/mL, and deficiency is defined as below 20 ng/mL.